Oramed Pharmaceuticals
ORMP
ORMP
52 hedge funds and large institutions have $16.6M invested in Oramed Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 15 increasing their positions, 18 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
17% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 18
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Holders
52
Holding in Top 10
1
Calls
$26K
Puts
$4K
Top Buyers
| 1 | +$806K | |
| 2 | +$91.9K | |
| 3 | +$53.5K | |
| 4 |
SG Americas Securities
New York
|
+$50K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$47.3K |
Top Sellers
| 1 | -$166K | |
| 2 | -$156K | |
| 3 | -$113K | |
| 4 |
Two Sigma Investments
New York
|
-$98.4K |
| 5 |
MAM
Marquette Asset Management
Minneapolis,
Minnesota
|
-$80.6K |
